Tag: pharma sector news
IPC Issues Drug Safety Alert Linking Clonidine to Hyponatremia Risk
The Indian Pharmacopoeia Commission (IPC), acting through the National Coordination Centre of the Pharmacovigilance Programme of India (NCC-PvPI), has officially issued a critical drug...
Novartis Strengthens Autoimmune Disease Portfolio with Key Highlights from EULAR 2026
Novartis AG concluded a defining presence at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress today at ExCeL London, presenting pivotal findings from 31...
AstraZeneca’s Ultomiris®️ Cuts Proteinuria by 43.4% in Phase – 3 Trial
Alexion, AstraZeneca Rare Disease, announced positive results from a prespecified interim analysis of the global Phase III I CAN trial. The data demonstrate...
Drug Control Raid in Howrah: Large Stock of Medicines Seized, Samples Sent for Testing
A multi-day operation by the Drug Control Department in Howrah has led to the seizure of a large quantity of medicines from a godown...
Lupin Gets U.S. FDA Approval for Ranluspec™ to Treat Retinal Disorders
Lupin Limited has secured U.S. FDA approval for Ranluspec™ (ranibizumab-hkdz), an interchangeable biosimilar to Genentech’s Lucentis® — a milestone that reshapes patient access to sight-saving biologics across...
Glenmark Launches Generic Vimpat®️ Injection in the US to Expand Injectable Portfolio
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of its Lacosamide Injection USP, 200mg/mL,20mg/mL, 10mg/mL available in Single-Dose Vials, as detailed in the official...